Richard E. OLSON

Person

Orange, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
- Patent number 12,180,478
- Issue date Dec 31, 2024
- Bristol-Myers Squibb Company
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for modulating Tau expression
- Patent number 12,163,131
- Issue date Dec 10, 2024
- HOFFMANN-LA ROCHE INC.
- Peter Hagedorn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Phosphorus (V)-based reagents, processes for the preparation thereo...
- Patent number 12,077,558
- Issue date Sep 3, 2024
- Bristol-Myers Squibb Company
- Michael Anthony Schmidt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted bicyclic compounds useful as T cell activators
- Patent number 11,964,973
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Naphthyridinone compounds useful as T cell activators
- Patent number 11,866,430
- Issue date Jan 9, 2024
- Bristol-Myers Squibb Company
- Louis S. Chupak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of selecting therapeutic molecules
- Patent number 11,761,951
- Issue date Sep 19, 2023
- Bristol-Myers Squibb Company
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for modulating Tau expression
- Patent number 11,753,640
- Issue date Sep 12, 2023
- HOFFMANN-LA ROCHE INC.
- Peter Hagedorn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 11,713,316
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phosphorous (V)-based reagents, processes for the preparation there...
- Patent number 11,613,554
- Issue date Mar 28, 2023
- Bristol-Myers Squibb Company
- Michael Anthony Schmidt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridopyrimidinonyl compounds useful as T cell activators
- Patent number 11,584,747
- Issue date Feb 21, 2023
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
- Patent number 11,447,775
- Issue date Sep 20, 2022
- Bristol-Myers Squibb Company
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
- Patent number 11,359,197
- Issue date Jun 14, 2022
- Bristol-Myers Squibb Company
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for modulating Tau expression
- Patent number 11,279,929
- Issue date Mar 22, 2022
- Hoffmann-La Roche, Inc.
- Peter Hagedorn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Tau antisense oligomers and uses thereof
- Patent number 11,077,132
- Issue date Aug 3, 2021
- F. Hoffmann-La Roche AG
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CAMK2D antisense oligonucleotides and uses thereof
- Patent number 11,058,767
- Issue date Jul 13, 2021
- Bristol-Myers Squibb Company
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,954,238
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tau antisense oligomers and uses thereof
- Patent number 10,799,523
- Issue date Oct 13, 2020
- F. Hoffmann-La Roche AG
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,669,272
- Issue date Jun 2, 2020
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Difluoromethoxy compound with low bioactivation potential for the r...
- Patent number 9,833,454
- Issue date Dec 5, 2017
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor lig...
- Patent number 9,796,713
- Issue date Oct 24, 2017
- Bristol-Myers Squibb Company
- Ivar M. McDonald
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor lig...
- Patent number 9,708,323
- Issue date Jul 18, 2017
- Bristol-Myers Squibb Company
- Ivar M. McDonald
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use the...
- Patent number 9,403,776
- Issue date Aug 2, 2016
- Albany Molecular Research, Inc.
- Bruce F. Molino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and...
- Patent number 9,096,546
- Issue date Aug 4, 2015
- Albany Molecular Research, Inc.
- Peter R. Guzzo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and u...
- Patent number 9,045,468
- Issue date Jun 2, 2015
- Albany Molecular Research, Inc.
- Peter R. Guzzo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryloxy- and heteroaryloxy-substituted tetrahydrobenzazepines and u...
- Patent number 8,987,252
- Issue date Mar 24, 2015
- Albany Molecular Research, Inc.
- Shuang Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective NR2B antagonists
- Patent number 8,841,301
- Issue date Sep 23, 2014
- Bristol-Myers Squibb Company
- Dalton King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use the...
- Patent number 8,791,101
- Issue date Jul 29, 2014
- Albany Molecular Research, Inc.
- Bruce F. Molino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective NR2B antagonists
- Patent number 8,722,670
- Issue date May 13, 2014
- Bristol-Myers Squibb Company
- Dalton King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the reduction of β-amyloid production
- Patent number 8,710,061
- Issue date Apr 29, 2014
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the reduction of beta-amyloid production
- Patent number 8,637,525
- Issue date Jan 28, 2014
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20240400563
- Publication date Dec 5, 2024
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR
- Publication number 20240108654
- Publication date Apr 4, 2024
- Juno Therapeutics, Inc.
- David G. KUGLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION
- Publication number 20240026360
- Publication date Jan 25, 2024
- HOFFMANN-LA ROCHE INC.
- Peter HAGEDORN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THERE...
- Publication number 20230242569
- Publication date Aug 3, 2023
- Bristol-Myers Squibb Company
- Michael Anthony SCHMIDT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF
- Publication number 20230193260
- Publication date Jun 22, 2023
- Bristol-Myers Squibb Company
- Richard E. OLSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230151007
- Publication date May 18, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS
- Publication number 20230118629
- Publication date Apr 20, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED QUINAZOLINYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230094758
- Publication date Mar 30, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS
- Publication number 20230089255
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Susan WEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230086933
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTI...
- Publication number 20230061608
- Publication date Mar 2, 2023
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20220324859
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
- Publication number 20220213484
- Publication date Jul 7, 2022
- Bristol-Myers Squibb Company
- Brian R. ANDERSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION
- Publication number 20220177884
- Publication date Jun 9, 2022
- HOFFMANN-LA ROCHE INC.
- Peter HAGEDORN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TAU ANTISENSE OLIGOMERS AND USES THEREOF
- Publication number 20220143064
- Publication date May 12, 2022
- F. Hoffmann-La Roche AG
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ALPHA-SYNUCLEIN ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
- Publication number 20220119811
- Publication date Apr 21, 2022
- Roche Innovation Center Copenhagen A/S
- Peter HAGEDORN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
- Publication number 20210378652
- Publication date Dec 9, 2021
- Bristol-Myers Squibb Company
- Richard E. OLSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGONUCLEOTIDES FOR MODULATING MYH7 EXPRESSION
- Publication number 20210371860
- Publication date Dec 2, 2021
- Roche Innovation Center Copenhagen A/S
- Peter HAGEDORN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210277004
- Publication date Sep 9, 2021
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210188845
- Publication date Jun 24, 2021
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antisense Oligonucleotides Targeting Alpha-Synuclein and Uses Thereof
- Publication number 20210180065
- Publication date Jun 17, 2021
- Bristol-Myers Squibb Company
- Richard E. OLSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION
- Publication number 20210123054
- Publication date Apr 29, 2021
- HOFFMANN-LA ROCHE INC.
- Peter HAGEDORN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210061802
- Publication date Mar 4, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF
- Publication number 20200362347
- Publication date Nov 19, 2020
- Bristol-Myers Squibb Company
- Richard E. OLSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF
- Publication number 20200354720
- Publication date Nov 12, 2020
- Bristol-Myers Squibb Company
- Richard E. OLSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20200109140
- Publication date Apr 9, 2020
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION
- Publication number 20200010831
- Publication date Jan 9, 2020
- HOFFMANN-LA ROCHE, INC.
- Peter HAGEDORN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of Selecting Therapeutic Molecules
- Publication number 20190383797
- Publication date Dec 19, 2019
- Bristol-Myers Squibb Company
- Richard E. OLSON
- G01 - MEASURING TESTING
Information Patent Application
NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION...
- Publication number 20190322694
- Publication date Oct 24, 2019
- Bristol-Myers Squibb Company
- Michael Anthony SCHMIDT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
- Publication number 20190275148
- Publication date Sep 12, 2019
- Bristol-Myers Squibb Company
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Richard E. OLSON

Person

Patents Grantslast 30 patents

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Oligonucleotides for modulating Tau expression

Phosphorus (V)-based reagents, processes for the preparation thereo...

Substituted bicyclic compounds useful as T cell activators

Naphthyridinone compounds useful as T cell activators

Methods of selecting therapeutic molecules

Oligonucleotides for modulating Tau expression

Substituted naphthyridinone compounds useful as T cell activators

Phosphorous (V)-based reagents, processes for the preparation there...

Substituted pyridopyrimidinonyl compounds useful as T cell activators

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Oligonucleotides for modulating Tau expression

Tau antisense oligomers and uses thereof

CAMK2D antisense oligonucleotides and uses thereof

Substituted naphthyridinone compounds useful as T cell activators

Tau antisense oligomers and uses thereof

Substituted naphthyridinone compounds useful as T cell activators

Difluoromethoxy compound with low bioactivation potential for the r...

Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor lig...

Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor lig...

Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use the...

Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and...

2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and u...

Aryloxy- and heteroaryloxy-substituted tetrahydrobenzazepines and u...

Selective NR2B antagonists

Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use the...

Selective NR2B antagonists

Compounds for the reduction of β-amyloid production

Compounds for the reduction of beta-amyloid production

Patents Applicationslast 30 patents

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR

OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION

PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THERE...

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS

SUBSTITUTED QUINAZOLINYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS

SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTI...

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION

TAU ANTISENSE OLIGOMERS AND USES THEREOF

ALPHA-SYNUCLEIN ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

OLIGONUCLEOTIDES FOR MODULATING MYH7 EXPRESSION

NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS

Antisense Oligonucleotides Targeting Alpha-Synuclein and Uses Thereof

OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION

Methods of Selecting Therapeutic Molecules

NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION...

CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF